Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers
- PMID: 24493004
- DOI: 10.1039/c3lc50993a
Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers
Abstract
Exosomes/microvesicles are known to shuttle biological signals between cells, possibly by transferring biological signal components such as encapsulated RNAs and proteins, plasma membrane proteins, or both. Therefore exosomes are being considered for use as RNA and protein delivery vehicles for various therapeutic applications. However, living cells in nature secrete only a small number of exosomes, and procedures to collect them are complex; these complications impede their use in mass delivery of components to targeted cells. We propose a novel and efficient method that forces cells through hydrophilic microchannels to generate artificial nanovesicles. These mimetic nanovesicles contain mRNAs, intracellular proteins and plasma membrane proteins, and are shaped like cell-secreted exosomes. When recipient cells are exposed to nanovesicles from embryonic stem cells, mRNAs of Oct 3/4 and Nanog are transferred from embryonic stem cells to the target cells. This result suggests that mimetic nanovesicles can be used as vehicles to deliver RNA. This nanovesicle formation method is expected to be used in exosome research and to have applications in drug and RNA-delivery systems.
Similar articles
-
Large-scale generation of cell-derived nanovesicles.Nanoscale. 2014 Oct 21;6(20):12056-64. doi: 10.1039/c4nr02391a. Epub 2014 Sep 5. Nanoscale. 2014. PMID: 25189198
-
Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.ACS Nano. 2013 Sep 24;7(9):7698-710. doi: 10.1021/nn402232g. Epub 2013 Sep 4. ACS Nano. 2013. PMID: 24004438
-
Nanovesicles engineered from ES cells for enhanced cell proliferation.Biomaterials. 2014 Nov;35(34):9302-10. doi: 10.1016/j.biomaterials.2014.07.047. Epub 2014 Aug 15. Biomaterials. 2014. PMID: 25132601
-
Post isolation modification of exosomes for nanomedicine applications.Nanomedicine (Lond). 2016 Jul;11(13):1745-56. doi: 10.2217/nnm-2016-0102. Epub 2016 Jun 27. Nanomedicine (Lond). 2016. PMID: 27348448 Free PMC article. Review.
-
[EXTRACELLULAR VESICLES: INTERCELLULAR INFORMATION FLOW AND MEDICAL APPLICATIONS].Tsitologiia. 2015;57(8):551-62. Tsitologiia. 2015. PMID: 26591566 Review. Russian.
Cited by
-
Recent advances in nanomaterials for the treatment of spinal cord injury.Mater Today Bio. 2022 Dec 17;18:100524. doi: 10.1016/j.mtbio.2022.100524. eCollection 2023 Feb. Mater Today Bio. 2022. PMID: 36619202 Free PMC article. Review.
-
Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes.J Extracell Vesicles. 2018 Jan 17;7(1):1422676. doi: 10.1080/20013078.2017.1422676. eCollection 2018. J Extracell Vesicles. 2018. PMID: 29372017 Free PMC article. Review.
-
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.Front Cell Dev Biol. 2021 Sep 20;9:734720. doi: 10.3389/fcell.2021.734720. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34616741 Free PMC article. Review.
-
Co-culture engineering: a promising strategy for production of engineered extracellular vesicle for osteoarthritis treatment.Cell Commun Signal. 2024 Jan 10;22(1):29. doi: 10.1186/s12964-023-01467-9. Cell Commun Signal. 2024. PMID: 38200606 Free PMC article. Review.
-
Exploring extracellular vesicles in zoonotic helminth biology: implications for diagnosis, therapeutic and delivery.Front Cell Infect Microbiol. 2024 Aug 6;14:1424838. doi: 10.3389/fcimb.2024.1424838. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39165921 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials